C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism
1 Section of Clinical Physiology, Department of Surgical Sciences and 2 Section of Cardiology, Department of Medicine, Karolinska Hospital, S-171 76 Stockholm, Sweden Submitted 2 January 2003 ; accepted in final form 4 June 2003 Proinsulin C-peptide has been shown to increase muscle blood flow in ty...
Gespeichert in:
Veröffentlicht in: | American journal of physiology: endocrinology and metabolism 2003-10, Vol.285 (4), p.E864-E870 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 1 Section of Clinical Physiology, Department of Surgical Sciences and 2 Section of Cardiology, Department of Medicine, Karolinska Hospital, S-171 76 Stockholm, Sweden
Submitted 2 January 2003
; accepted in final form 4 June 2003
Proinsulin C-peptide has been shown to increase muscle blood flow in type 1 diabetic patients. The underlying mechanism is not fully understood. The aim of this study was to evaluate if the vasodilator effect of C-peptide is mediated by nitric oxide (NO). Eleven type 1 diabetic patients were studied two times and randomized to administration of intravenous and intra-arterial infusion of C-peptide or saline. Forearm blood flow (FBF) was measured by venous occlusion plethysmography during infusion of C-peptide or saline before, during, and after NO synthase (NOS) blockade. Endothelium-dependent and -independent vasodilatation was evaluated by administration of acetylcholine and sodium nitroprusside, respectively. FBF increased by 35% during intravenous C-peptide ( P < 0.01) but not during saline infusion (2%, not significant). NOS blockade resulted in a more pronounced reduction in FBF during intravenous C-peptide than during saline infusion (41 vs. 26%, P < 0.05). Intra-arterial C-peptide failed to increase FBF during NOS blockade. However, when C-peptide was given after the recovery from NOS blockade, FBF rose by 30% ( P < 0.001). The vasodilator effects of acetylcholine and nitroprusside were not influenced by C-peptide. It is concluded that the stimulatory effect of C-peptide on FBF in type 1 diabetic patients is mediated via the NO system and that C-peptide increases basal endothelial NO levels.
acetylcholine; insulin; N G -monomethyl- L -arginine; sodium nitroprusside; venous occlusion plethysmography
Address for reprint requests and other correspondence: B.-L. Johansson, Dept. of Surgical Sciences, Division of Clinical Physiology N1:05, Karolinska Hospital, SE-171 76 Stockholm, Sweden. |
---|---|
ISSN: | 0193-1849 1522-1555 |
DOI: | 10.1152/ajpendo.00001.2003 |